Statins after high-risk prostate cancer diagnosis linked to 42% lower cancer death
A shared summary of a cohort study of high-risk prostate cancer patients: post-diagnosis statin use (atorvastatin, pravastatin, rosuvastatin, not lovastatin) lowered prostate cancer mortality 42%, statins plus metformin 54%, and metformin alone showed no benefit.
